Skip to main content

Table 1 Biometric parameters of control or diabetic FVB and ALDH2 mice

From: RETRACTED ARTICLE: Mitochondrial aldehyde dehydrogenase (ALDH2) protects against streptozotocin-induced diabetic cardiomyopathy: role of GSK3β and mitochondrial function

Parameter

FVB

FVB-STZ

ALDH2

ALDH2-STZ

Body weight (g)

30.3 ± 1.3

24.2 ± 0.7a

29.5 ± 1.1

26.1 ± 0.8a

Heart weight (mg)

165 ± 9

171 ± 8

163 ± 6

159 ± 5

Heart/body weight ratio (mg/g)

5.45 ± 0.19

7.23 ± 0.43a

5.66 ± 0.26

6.16 ± 0.18b

Liver weight (g)

1.54 ± 0.07

1.44 ± 0.07

1.52 ± 0.05

1.46 ± 0.06

Liver/body weight (mg/g)

51.2 ± 1.4

59.4 ± 2.3a

51.9 ± 1.9

54.9 ± 1.9

Kidney weight (g)

0.45 ± 0.03

0.39 ± 0.02

0.42 ± 0.02

0.40 ± 0.03

Kidney/body weight (mg/g)

14.8 ± 0.4

16.1 ± 0.8

14.4 ± 0.4

15.4 ± 0.8

Plasma insulin (ng/mL)

0.27 ± 0.03

0.05 ± 0.01a

0.28 ± 0.03

0.06 ± 0.02a

Fasting blood glucose (mM)

5.50 ± 0.26

19.7 ± 1.5a

5.43 ± 0.18

18.5 ± 1.7a

Postprandial blood glucose (mM)

9.94 ± 0.67

25.3 ± 1.5a

10.57 ± 0.54

26.5 ± 1.8a

Plasma free fatty acids (mM)

1.00 ± 0.11

1.30 ± 0.04a

1.00 ± 0.15

1.25 ± 0.08a

  1. Mean ± SEM, n = 21 to 22 mice per group. a P < 0.05 versus FVB group; b P < 0.05 versus FVB-STZ group.